Archives

ZEISS Announces Diffraction Contrast Tomography for 3D Materials Science

December 4, 2016

 

ZEISS Announces Diffraction Contrast Tomography for 3D Materials Science

New LabDCT Unlocks Crystallographic Information with Xradia 3D X-ray Microscopes

PLEASANTON, Calif. , July 29, 2015 – The first laboratory-based diffraction contrast tomography (DCT) system for 3D grain imaging was launched today by Carl Zeiss X-ray Microscopy, a pioneer in bringing synchrotron imaging capabilities to the researcher’s laboratory. The LabDCT™ advanced imaging module enables a handshake between theoretical and practical worlds for predictive materials design by visualizing grain orientations in 3D. Originally developed at a limited number of synchrotron X-ray facilities, this marks the first commercial offering of DCT on a laboratory X-ray microscope (XRM).

 
Non-destructive Characterization
 

LabDCT non-destructively obtains 3D crystallographic information from polycrystalline samples. Combining grain orientation information with microstructural features such as cracks, porosity, and inclusions opens new possibilities for characterization of damage, deformation and growth mechanisms related to 3D materials science. Imaging these microscopic features in three dimensions with advanced contrast techniques enhances the collective understanding of fundamental materials mechanisms behind these processes.

Henning Friis Poulsen, Professor of Physics at the Technical University of Denmark, said, “Since its development more than a decade ago at synchrotron sources, demand for DCT has steadily increased. Making DCT widely available via laboratory-based systems promises to fuel materials science research efforts, taking it from proof-of-concept to detailed studies of microstructural controlled materials phenomena.”

 
4D and In Situ Studies
 

Exposing samples to in situ sample environments within the microscope, or to an extended time evolution “4D” experiment (across days, weeks, months), is a unique strength of laboratory-based XRM experiments compared to the synchrotron. LabDCT extends the ability of 4D and in situ microstructure evolution studies to explore the influence of crystallography on materials microstructures in a laboratory tomography instrument for the first time.

Philip Withers, Professor of Materials Science and Director of the Manchester Henry Moseley X-ray Imaging Facility, noted, “LabDCT represents a major step towards addressing the grand multi-scale challenge in 3D materials science. By providing non-destructive 3D information about the grain orientations and morphologies, LabDCT promises to deepen our understanding of microstructure-property relationships and accelerate the development of micromechanical models for a variety of materials degradation and deformation processes.”

 
Correlative Microscopy
 

Following a 4D evolution experiment, possible only through a non-destructive imaging process, a sample may be sent to the electron microscope or focused ion beam (FIB-SEM) microscope for complementary high-resolution post-mortem investigation such as EDS or EBSD of identified volumes of interest. Such correlative workflows, efficiently enabled by the ZEISS Atlas 5 platform, point to the future of modern microscopy and seamlessly leverage the multi-modal, multi-scale and multi-dimensional characterization platforms provided by ZEISS..

 
Synchrotron-quality in the Lab
 

According to Dr. Kevin Fahey, Senior Vice President, Global Marketing and Market Segments for ZEISS Microscopy, “The ability to do 4D experiments in one’s own lab that allow you to observe grain growth and microstructural evolution in real systems enables researchers to expand their range of materials systems study, and to study evolution like corrosion over time. This represents another example in a long legacy at Carl Zeiss X-ray Microscopy of bringing synchrotron-quality X-ray imaging to the laboratory.”.

 
Availability
 

LabDCT is immediately available as an optional module for the ZEISS Xradia 520 Versa 3D X-ray microscope. LabDCT includes GrainMapper3D analysis software developed by Xnovo Technology ApS..

 

 

 

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

New X-ray microscope strengthens TWI imaging capability

December 4, 2016

A state-of-the-art X-ray microscope (XRM), capable of generating manipulable, three-dimensional renderings of objects in extraordinary detail, has been installed at TWI.

24 June 2015

The Zeiss Xradia Versa 520, located in TWI’s newly expanded Cambridge headquarters, greatly enhances the opportunities for research available to students undertaking postgraduate degrees at the National Structural Integrity Research Centre (NSIRC), and adds another dimension to the range of inspection and analysis services TWI is able to offer its Member companies.

The microscope has applications across a number of industry sectors, including oil and gas, aerospace, medical and electronics.

To facilitate non-destructive testing and materials research, it can be used to characterise materials, observe fractures and their mechanics and perform in-situ, time-dependent (4D) tensile compression studies. In electronics it can be used for failure analysis, package construction analysis and manufacturing process optimisation.

The XRM, which is capable of submicron imaging, uses a first-of-its-kind compositional contrast system and features a true spatial resolution of 0.7µm and a minimum voxel size of 70nm. Where traditional tomography relies on a single stage of geometric magnification, this high-specification XRM features a unique two-stage process based on synchrotron-calibre optics.

Advanced capabilities include a high-aspect-ratio tomography mode for flat samples and the dual energy contrast optimiser, which allows imaging of samples that contain a range of materials with similar radiographic contrast. The XRM is a tool that drastically expands the imaging capabilities for engineers, researchers and students studying at NSIRC.

The microscope was purchased using money awarded by the Higher Education Funding Council for England to Brunel University London, lead academic partner at NSIRC and longstanding collaborator with TWI through the Brunel Innovation Centre.

A video showing a three-dimensional rendering of an ultrasonic transducer viewed through the microscope can be viewed on the TWI YouTube channel:

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

ZEISS Offers New Xradia Ultra Load Stage to Introduce In situ Nanomechanical Testing in 3D

December 4, 2016

ZEISS Offers New Xradia Ultra Load Stage to Introduce In situ Nanomechanical Testing in 3D

Pleasanton, CA, USA, March 11, 2015
ZEISS announces the new Ultra Load Stage for ZEISS Xradia Ultra 3D X-ray microscopes (XRM). Xradia Ultra Load Stage uniquely enables in situ nanomechanical testing—compression, tension, indentation—with non-destructive 3D tomographic imaging. For the first time, researchers will be able to image the evolution of structure in 3D under load down to 50 nm resolution. This new capability applies to a wide range of interests, covering both engineered and natural materials.

Of particular interest to materials scientists, Xradia Ultra Load Stage explores a new critical length scale for in situ materials characterization, enabling researchers to observe internal features such as nanoscale cracks and voids that ultimately lead to deformation and failure at the macroscale. This capability supports “materials by design,” a concept that enables the development of unique new materials for function-specific applicability, such as lighter, stronger fiber composites for airplane wings; more durable concrete for building materials; and biomimetic materials reproducing the advanced mechanical properties of many natural structures.

The University of Manchester in Manchester, UK has performed 3D in situ imaging of crack growth using Xradia Ultra Load Stage in nanoindentation mode to understand how cracks grow in dentin, the nano-composite that forms the bulk of teeth. Philip Withers, Professor of Materials Science and Director of the Manchester Henry Moseley X-ray Imaging Facility, says, “In situ nanomechanical testing in the Xradia Ultra X-ray microscope has enabled us to link the nanoscale 3D structure of a material directly to its performance. For the first time we can now undertake time-lapse 3D imaging with phase contrast to follow the nucleation and growth of defects and cracks in both natural and synthetic nanostructured materials.”

Los Alamos National Laboratory has already studied a variety of materials with the instrument, including glass microspheres, foams, metal alloys, and single microcrystals. A team led by Brian M. Patterson uses the stage to better understand damage initiation and growth in materials, gaining insight into how processing affects mechanical response.

Dr. Kevin Fahey, chief materials scientist and head of Carl Zeiss X-ray Microscopy, notes that the development of Ultra Load Stage was undertaken in a continuing effort to enable the company’s customers to advance science with unique new capabilities. “ZEISS Xradia Ultra X-ray microscopes provide the highest resolution available in non-destructive 3D X-ray imaging outside a synchrotron facility. Now, our customers are able to bridge the lengthscale/force gap between the micron scale and in situ SEM/TEM, visualizing and quantifying 3D nanostructures under load. This is a completely unique capability that offers new opportunities to connect small scale evolution processes with those observed in micron scale XRM and bulk material testing.”

Ultra Load Stage satisfies a void in the current availability of mechanical testing and imaging approaches, offering new capabilities to observe internal processes at nanoscale resolution. Until now, electron microscopy techniques provided resolution down to the nanometer range but are limited to surface imaging (SEM) or required extremely thin samples whose mechanical behavior will be strongly affected by surface effects (TEM).
Ultra Load Stage comprises a piezomechanical actuator with closed loop position control, a strain gauge force sensor and anvil sets that can be configured for three different operating modes, compression, tension, and indentation. It is available immediately.

Visit www.zeiss.com/xrm for more information about ZEISS Xradia 3D X-ray microscopes. To download information about Xradia Ultra Load Stage, visit http://info.xradia.com/Xradia-Ultra-Load-Stage.html.

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

ZEISS Offers New Autoloader for 3D X-ray Imaging

December 4, 2016

 

ZEISS Offers New Autoloader for 3D X-ray Imaging

Extends Efficiency & Optimizes Use of Xradia Versa Platforms

Pleasanton, CA – July 28, 2014 – ZEISS announces a new option for Xradia Versa 3D X-ray microscopes for submicron imaging: the XRM Autoloader for automated sample handling. Autoloader helps gain critical efficiency and maximizes utilization of Xradia Versa systems by reducing the user-instrument interaction for sample batches that can be run throughout the workday, overnight, and even over typically under-used weekend time.

Autoloader is flexible for handling diverse sample types in the same queue, offers workflow solutions for volume jobs, and also facilitates precise and repeatable sample measurements. It is especially valuable in industries where increased utilization can provide a positive impact on profitability. Users are able to set up queues of imaging jobs to maximize XRM usage, thus increasing effective throughput. As an additional convenience, users may receive automatic notification, including via their mobile devices if desired, of each successively completed scan.

In today’s time-sensitive applications, users benefit from the ability to perform a single batch set-up and allow the system to run automatically, sometimes for days. At the same time, they need flexibility to interrupt one batch to run a higher priority job if needed. Early users of the new Autoloader have improved the efficiency of sample handling by 17-30%. On the ZEISS Xradia 520 Versa, Autoloader enhances failure analysis in the semiconductor industry by facilitating the study of controlled collapse chip connections (C4), through silicon vias (TSV), micron-sized bump cracks, voids in substrates and a number of other issues. It also introduces efficiency in the oil and gas industry by setting a queue of up to 14 core plugs at one time.

We’re fortunate to work with the world’s leaders in electronics manufacturing and the oil and gas industry”, says Dr. Kevin Fahey, head of the ZEISS X-ray microscopy business. “To support their requirements to continually improve operational efficiency, we’re committed to continue evolving the power of 3D X-ray microscopy with innovations like Autoloader that streamline processes and deliver higher ROI and efficiency across the widest possible range of industrial applications.”

ZEISS XRM Autoloader is available immediately. It integrates seamlessly with Scout-and-Scan user interface versions 10.6 and higher and is a field upgrade option for ZEISS Xradia Versa systems. Autoloader is supplied with fourteen sample holders, and customers are able to select from five different styles. Additionally, ZEISS offers an open design architecture for the sample holders that enables users to create custom designs for their unique applications. Total load capability of the Autoloader is 1.5Kg.

For more information, visit http://www.zeiss.com/xrm for more information.

 

 

 

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

Xradia Announces X-ray Fluorescence Imaging Tool

December 4, 2016

Xradia Announces X-ray Fluorescence Imaging Tool

CONCORD, California – (Business Wire) – July 11, 2005: X-ray microscopy company Xradia, Inc. announced today the release of a new element-specific X-ray imaging tool for semiconductor metrology, Scanning Electron Microscopes (SEM) and Electron Probe Micro Analyzers.

The nanoXFiM X-ray fluorescence imager collects and images fluorescence X-rays characteristic of elements that emit them when exposed to X-ray or electron beams. The nanoXFiM images the spatial distribution of an element of interest in the sample, resolving feature sizes smaller than 100nm. Nearly all elements of the periodic table can be imaged in this manner. The first application of the nanoXFiM is in semiconductor manufacturing, using electron beam excitation to characterize production wafers in semiconductor wafer fabs.

The fluorescence imager also attaches to Scanning Electron Microscopes and Electron Probe Micro Analyzers, providing users with powerful new imaging capability, allowing non-destructive, element-specific subsurface imaging inside samples of interest. Resulting images are obtained by exploiting the ability of electron and X-ray beams to penetrate below the surface of the sample and produce element-specific fluorescence images that contain depth information.

“X-ray fluorescence imaging allows for the visualization of complex structures, one element at a time, in the domain of tens of nanometers,” said Dr. Wenbing Yun, Xradia founder and President. “This is a potent new tool for nanotechnology, biotech and semiconductor manufacturing with the potential to revolutionize the field of microscopy,” commented Bill Diamond, Xradia CEO. The nanoXFi is currently in production and shipping to initial OEM customers.

About Xradia, Inc.

Xradia, Inc. is a privately held company established in 2000 to commercialize high-resolution 3D X-ray microscopes for nondestructive inspection and nano-scale imaging. Initially targeted at failure analysis in the semiconductor IC industry, subsequent developments have led to a suite of commercial X-ray imaging products that have permitted expansion into markets that include basic research, metrology in semiconductor IC production, biomedical research and nanotechnology development. These advanced systems offer outstanding nondestructive imaging capabilities. These include nanometer resolution 3D imaging of complex objects, such as IC chips and biological specimens and element-specific imaging for process control and monitoring in IC manufacturing. The company also supplies advanced X-ray imaging components and state of the art imaging systems to the synchrotron research community. The company is rapidly expanding in 2005 in response to growing demand for its unique X-ray imaging products.

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

Xradia Announces $1.4M NIH Grant for Nano-scale X-ray Microscope

December 4, 2016

Xradia Announces $1.4M NIH Grant for Nano-scale X-ray Microscope

Concord, CA – September 29, 2005: Xradia, Inc., a developer and manufacturer of ultra-high-resolution X-ray imaging systems for 3D tomography and nanotechnology applications, today announced receipt of a $1.4 million grant from the National Institutes of Health (NIH) for the development of an ultra-high resolution X-ray microscope for the three-dimensional imaging of complex biological systems.

Nanotechnology is emerging as a critical field essential to enabling fundamental breakthroughs having tremendous potential for affecting biomedicine. In this respect, single-cell tomography using X-rays, has been identified as a major technology need by NIH. “With unique capabilities in developing high-resolution X-ray nano-tomography systems, Xradia is in an ideal position to meet this emerging need,” said Dr. Michael Feser, Engineering Vice President at Xradia.

The company will expand its product line by introducing a new X-ray tomography system designed specifically for biomedical applications. This new product will include capabilities of automated 3D tomographic imaging with single cell or tissue sections at 30nm resolution, and high throughput. A cryogenic sample stage will preserve samples in a frozen-hydrated state, and enable simple preparation without the need for sectioning. “The new X-ray microscope developed with these funds will bridge the gap between visible light and electron microscopy, and will provide biologists with a powerful and unique vision tool offering new insights on the structure and behavior of cellular organelles.” Said Dr. Wenbing Yun, company founder and President. Development of the new microscope is expected to be complete in less than twelve months.

About Xradia, Inc.

Xradia, Inc. is a privately held company established in 2000 to commercialize high-resolution X-ray microscopes for nondestructive inspection and nano-scale imaging. Initially targeted at failure analysis in the semiconductor IC industry, subsequent developments have led to a suite of commercial X-ray imaging products that have permitted expansion into markets that include metrology in semiconductor IC production, scientific equipment, biomedical research and nanotechnology development. These advanced systems offer outstanding nondestructive imaging capabilities. These include nanometer resolution 3D imaging of complex objects, such as IC chips and biological specimens and element-specific imaging for process control and monitoring in IC manufacturing. The company also supplies advanced X-ray imaging components and state of the art imaging systems to the synchrotron research community. The company is rapidly expanding in 2005 in response to demand for its unique X-ray imaging products.

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

Xradia Announces 3D X-ray Microscope

December 4, 2016

Xradia Announces 3D X-ray Microscope

CONCORD, California – (Business Wire) – October 17, 2005: X-ray microscopy company Xradia, Inc. announced today the launch of its new MicroXCT X-ray microscope, featuring full 3D tomography image reconstruction. The MicroXCT is designed for use in semiconductor packaging failure analysis and defect review, while offering powerful imaging capabilities for applications ranging from specialty materials to bio-tech and life sciences.

The MicroXCT is a stand-alone system incorporating a 150kV X-ray source, digital detector, sample stage with 360° rotation, X-ray enclosure, and computer for system control and image processing. The X-ray detector incorporates a proprietary design that provides significantly higher throughput than conventional systems resulting in an optical architecture that enables full sample rotation. This capability makes the MicroXCT unique in offering true 3D volumetric reconstructions of complex samples, such as integrated circuits, biological samples and MEMs devices.

The nanoXFiM X-ray fluorescence imager collects and images fluorescence X-rays characteristic of elements that emit them when exposed to X-ray or electron beams. The nanoXFiM images the spatial distribution of an element of interest in the sample, resolving feature sizes smaller than 100nm. Nearly all elements of the periodic table can be imaged in this manner. The first application of the nanoXFiM is in semiconductor manufacturing, using electron beam excitation to characterize production wafers in semiconductor wafer fabs.

The fluorescence imager also attaches to Scanning Electron Microscopes and Electron Probe Micro Analyzers, providing users with powerful new imaging capability, allowing non-destructive, element-specific subsurface imaging inside samples of interest. Resulting images are obtained by exploiting the ability of electron and X-ray beams to penetrate below the surface of the sample and produce element-specific fluorescence images that contain depth information.

“X-ray fluorescence imaging allows for the visualization of complex structures, one element at a time, in the domain of tens of nanometers,” said Dr. Wenbing Yun, Xradia founder and President. “This is a potent new tool for nanotechnology, biotech and semiconductor manufacturing with the potential to revolutionize the field of microscopy,” commented Bill Diamond, Xradia CEO. The nanoXFi is currently in production and shipping to initial OEM customers.

About Xradia, Inc.

Xradia, Inc. is a privately held company established in 2000 to commercialize high-resolution 3D X-ray microscopes for nondestructive inspection and nano-scale imaging. Initially targeted at failure analysis in the semiconductor IC industry, subsequent developments have led to a suite of commercial X-ray imaging products that have permitted expansion into markets that include basic research, metrology in semiconductor IC production, biomedical research and nanotechnology development. These advanced systems offer outstanding nondestructive imaging capabilities. These include nanometer resolution 3D imaging of complex objects, such as IC chips and biological specimens and element-specific imaging for process control and monitoring in IC manufacturing. The company also supplies advanced X-ray imaging components and state of the art imaging systems to the synchrotron research community. The company is rapidly expanding in 2005 in response to growing demand for its unique X-ray imaging products.

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

Xradia Announces $2.0M Contract for Hard X-ray Nanoprobe Instrument

December 4, 2016

Xradia Announces $2.0M Contract for Hard X-ray Nanoprobe Instrument

Concord, CA, and Argonne, IL – June 1, 2006: Xradia, Inc., a developer and manufacturer of ultra-high-resolution X-ray imaging systems for 3D tomography and nanotechnology applications, today announced the award of a $2M contract from the Argonne National Laboratory’s Center for Nanoscale Materials (CNM). The contract calls for the participation in the design and engineering of a high resolution hard X-ray nanoprobe instrument (NPI) for 30nm high-resolution elemental and structural analysis using scanning probe and full-field transmission X-ray microscopy. The NPI will be installed at the Hard X-ray Nanoprobe Beamline at Argonne’s Advanced Photon Source (APS) as part of a joint development effort between the CNM and APS.

High resolution X-ray microscopy is of growing importance for research and industry in such diverse fields as alternative energy, advanced semiconductor development, bio technology and life sciences, materials science and nanotechnology. The unique ability of X-rays to penetrate samples of interest non-destructively, combined with X-ray optics that enable high-resolution microscopy, gives researchers and engineers unprecedented access to knowledge about the inner structure and nature of objects both man-made and natural in origin. The NPI will be one of the major characterization tools at the Center for Nanoscale Materials. ‘The Hard X-ray Nanoprobe will provide X-ray characterization at a spatial resolution of 30nm which substantially exceeds the optical limit,’ said Dr. Eric Isaacs, Director of CNM. ‘When integrated with CNM’s materials synthesis, fabrication, theory and other characterization capabilities, the NPI will revolutionize the design of materials at the nanoscale,’ said Isaacs.

“This project will push the state of the art in X-ray microscopy to new levels of resolution, both in terms of X-ray optics, and precision mechanical design,” said Dr. Jörg Maser, principal researcher at the Center for Nanoscale Materials. “With their commercial leadership in X-ray optics, and turnkey X-ray microscope instrumentation, Xradia is specially qualified to contribute to the design and to execute much of the system construction,” said Maser.

“We are delighted to be teaming up with CNM on this critical program,” said Dr. Wenbing Yun, President and founder of Xradia. “Pushing X-ray optics to new levels of resolution, and marrying that with advanced system design and imaging software, opens up exciting new applications in a wide range of disciplines and also helps Xradia’s commercial systems stay at the forefront,” said Yun.

About Xradia, Inc.

Xradia, Inc. is a privately held company established in 2000 to commercialize high-resolution X-ray microscopes for nondestructive inspection and nano-scale imaging. Initially targeted at failure analysis in the semiconductor IC industry, subsequent developments have led to a suite of commercial X-ray imaging products that have permitted expansion into markets that include metrology in semiconductor IC production, scientific equipment, biomedical research and nanotechnology development.

About Argonne National Laboratory

The nation’s first national laboratory, Argonne National Laboratory conducts basic and applied scientific research across a wide spectrum of disciplines, ranging from high-energy physics to climatology and biotechnology. Since 1990, Argonne has worked with more than 600 companies and numerous federal agencies and other organizations to help advance America’s scientific leadership and prepare the nation for the future. Argonne is managed by the University of Chicago for the U.S. Department of Energy’s Office of Science.

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

Xradia Announces New X-ray Solutions for Advanced Semiconductor Packaging

December 4, 2016

Xradia Announces New X-ray Solutions for Advanced Semiconductor Packaging

Concord, CA – June 28 2006: Xradia, Inc., a developer and manufacturer of ultra-high-resolution X-ray imaging systems for 3D tomography and nanotechnology applications, today announced the sale of three of its MicroXCTTM 3D Transmission X-ray Microscopes, to semiconductor manufacturers for advanced packaging process development and failure analysis. Combining spatial resolution below 1.5µm and feature recognition of 500nm, with full 3D tomography capability, the MicroXCTTM is ideally suited to the engineering and failure analysis of next-generation semiconductor packages, including multi stacked die and flip-chip architectures. Two of the systems are being deployed to fabs in the US for advanced package development and the third is headed to Asia where it will be used to examine ball grid arrays.

“These system sales validate the importance of high-resolution X-ray tomography as a critical new analytical tool for semiconductor manufacturing,” said Dr. Wenbing Yun, founder and President of Xradia. “3D X-ray microscopy enables the non-destructive investigation of design features or process defects, thereby lowering development costs and speeding time to market, “said Yun. “The ROI of Xradia’s new X-ray microscope system was evident from the very first sample images,” said My Nguyen, senior researcher at Altera Corporation, one of the new system customers. “We are able to image features of interest not otherwise observable with other techniques. No sample prep means enormous cost savings and fast turn around time,” said Nguyen.

High resolution 3D X-ray tomography provides critical new imaging capability for semiconductor packaging, including C4 ball grid arrays, stacked die, solder bumps and packaging interconnects. Defects such as solder non-wet, cracks, voids, delamination, opens and shorts are readily imaged. New applications are also emerging for RoHS lead-free development and vias in ceramic packaging. Xradia also manufactures microscope systems with sub 50nm resolution for chip and die-level applications.

About Xradia, Inc.

Xradia, Inc. is a privately held company established in 2000 to commercialize high-resolution X-ray microscopes for nondestructive inspection and nano-scale imaging. Initially targeted at failure analysis in the semiconductor IC industry, subsequent developments have led to a suite of commercial X-ray imaging products that have permitted expansion into markets that include metrology in semiconductor IC production, scientific equipment, biomedical research and nanotechnology development.

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com

Xradia Inc. announced the closing of a $7 million equity in a series of D financing round

December 4, 2016

Xradia Inc. announced the closing of a $7 million equity in a series of D financing round

CONCORD, California – (Business Wire) – March 9, 2007: Concord-based Xradia Inc. announced the closing of a $7million equity in a series D financing round. Major investors included Harris & Harris Group Inc., an unnamed strategic investor, and a prior round investor. Xradia designs, manufactures and sells a suite of ultrahigh-resolution 3-D X-ray microscopes and fluorescence imaging systems. Applications include 3-D imaging for the semiconductor industry as biological specimens ranging from single cells to small animals.

About Xradia, Inc.

Xradia, Inc. is a privately held company established in 2000 to commercialize high-resolution 3D X-ray microscopes for nondestructive inspection and nano-scale imaging. Initially targeted at failure analysis in the semiconductor IC industry, subsequent developments have led to a suite of commercial X-ray imaging products that have permitted expansion into markets that include basic research, metrology in semiconductor IC production, biomedical research and nanotechnology development. These advanced systems offer outstanding nondestructive imaging capabilities. These include nanometer resolution 3D imaging of complex objects, such as IC chips and biological specimens and element-specific imaging for process control and monitoring in IC manufacturing. The company also supplies advanced X-ray imaging components and state of the art imaging systems to the synchrotron research community. The company is rapidly expanding in 2005 in response to growing demand for its unique X-ray imaging products.

About ZEISS
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, ZEISS has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. ZEISS is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.

About Carl Zeiss Microscopy
The Microscopy business group at ZEISS is the world’s only manufacturer of light, X-ray and electron microscopes. The company’s extensive portfolio enables research and routine applications in the life and materials sciences. The product range includes light and laser scanning microscopes, X-ray microscopes, electron and ion microscopes and spectrometer modules. Users are supported for software for system control, image capture and editing. The Microscopy business group has sales companies in 33 countries. Application and service specialists support customers around the globe in demo centers and on site. The business group is headquartered in Jena, Germany. Additional production and development sites are in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK and Peabody, MA and Pleasanton, CA in the USA. The company has around 2,800 employees and generates revenue of 650 million euros. www.zeiss.de/press

Press contacts
Dr. Jochen Tham
ZEISS, Microscopy
Phone +49 3641 64-3949
Email: jochen.tham@zeiss.com

Brenda Ropoulos
ZEISS, Carl Zeiss X-ray Microscopy
Phone +1 510 414 6772
Email: brenda.ropoulos@zeiss.com